• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Galena Biopharma, Inc. (GALE)

    -NasdaqCM
    1.57 Down 0.05(3.09%) Dec 19, 4:00PM EST
    |After Hours : 1.59 Up 0.02 (1.27%) Dec 19, 7:57PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 2,487   -   -  
    Cost of Revenue520   -   -  
    Gross Profit 1,967   -   -  
    Operating Expenses
    Research Development21,076  14,614  3,851  
    Selling General and Administrative14,600  6,585  8,635  
    Non Recurring -   -   -  
    Others131   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (33,840) (21,199) (12,486)
    Income from Continuing Operations
    Total Other Income/Expenses Net(40,979)(13,145)9,086  
    Earnings Before Interest And Taxes(75,626)(34,377)(3,407)
    Interest Expense -   -   -  
    Income Before Tax(75,626)(34,377)(3,407)
    Income Tax Expense1,052  (1,052) -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(76,678)(33,325)(3,407)
    Non-recurring Events
    Discontinued Operations -  (1,644)(8,078)
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (76,678) (34,969) (11,485)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (76,678) (34,969) (11,485)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.